Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid Cancer

por Larson, Steven M., Osborne, Joseph R., Grewal, Ravinder K., Tuttle, R. Michael
Publicado 2017

TMSOTf assisted synthesis of 2’-deoxy-2’-[(18)F]fluoro-β-D-arabinofuranosylcytosine ([(18)F]FAC)

por Gangangari, Kishore K., Humm, John L., Larson, Steven M., Pillarsetty, Naga Vara Kishore
Publicado 2018

CAR Chase: Where Do Engineered Cells Go in Humans?

por Krebs, Simone, Dacek, Megan M., Carter, Lukas M., Scheinberg, David A., Larson, Steven M.
Publicado 2020

Optimizing reconstruction parameters for quantitative (124)I-PET in the presence of therapeutic doses of (131)I

por Fanchon, Louise M., Beattie, Bradley J., Pentlow, Keith, Larson, Steven M., Humm, John L.
Publicado 2021

Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer

por Anand, Aseem, Heller, Glenn, Fox, Joseph, Danila, Daniel C., Bjartell, Anders, Edenbrandt, Lars, Larson, Steven M., Scher, Howard I., Morris, Michael J.
Publicado 2022

Portable PET probes are a novel tool for intraoperative localization of tumor deposits

por Strong, Vivian E, Galanis, Charles J, Riedl, Christopher C, Longo, Valerie A, Daghighian, Farhad, Humm, John L, Larson, Steven M, Fong, Yuman
Publicado 2009

Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

por Buchegger, Franz, Larson, Steven M., Mach, Jean-Pierre, Chalandon, Yves, Dietrich, Pierre-Yves, Cairoli, Anne, Prior, John O., Romero, Pedro, Speiser, Daniel E.
Publicado 2013

Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide

por Anand, Aseem, Morris, Michael J., Larson, Steven M., Minarik, David, Josefsson, Andreas, Helgstrand, John T., Oturai, Peter S., Edenbrandt, Lars, Røder, Martin Andreas, Bjartell, Anders
Publicado 2016

Prospective evaluation of (18)F-FDG positron emission tomography in the preoperative staging of patients with hepatic colorectal metastases

por Akhurst, Tim, Gönen, Mithat, Baser, Raymond E., Schwartz, Lawrence H., Tuorto, Scott, Brody, Lynn A., Covey, Anne, Brown, Karen T., Larson, Steven M., Fong, Yuman
Publicado 2022

In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)

por Pankov, Dmitry, Sjöström, Ludvig, Kalidindi, Teja, Lee, Sang-Gyu, Sjöström, Kjell, Gardner, Rui, McDevitt, Michael R., O’Reilly, Richard, Thorek, Daniel L.J., Larson, Steven M., Veach, Darren, Ulmert, David
Publicado 2017

Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors

por Pandit-Taskar, Neeta, O’Donoghue, Joseph A, Divgi, Chaitanya R, Wills, Eze A, Schwartz, Lawrence, Gönen, Mithat, Smith-Jones, Peter, Bander, Neil H, Scher, Howard I, Larson, Steven M, Morris, Michael J
Publicado 2015

I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma

por Carrasquillo, Jorge A., O’Donoghue, Joseph A., Beylergil, Volkan, Ruan, Shutian, Pandit-Taskar, Neeta, Larson, Steven M., Smith-Jones, Peter M., Lyashchenko, Serge K., Ohishi, Norihisa, Ohtomo, Toshihiko, Abou-Alfa, Ghassan K.
Publicado 2018

Pilot study of (68)Ga-DOTA-F(ab′)(2)-trastuzumab in patients with breast cancer

por Beylergil, Volkan, Morris, Patrick G., Smith-Jones, Peter M., Modi, Shanu, Solit, David, Hudis, Clifford A., Lu, Yang, O’Donoghue, Joseph, Lyashchenko, Serge K., Carrasquillo, Jorge A., Larson, Steven M., Akhurst, Timothy J.
Publicado 2013

Theranostic pretargeted radioimmunotherapy of internalizing solid tumor antigens in human tumor xenografts in mice: Curative treatment of HER2-positive breast carcinoma

por Cheal, Sarah M., Xu, Hong, Guo, Hong-fen, Patel, Mitesh, Punzalan, Blesida, Fung, Edward K., Lee, Sang-gyu, Bell, Meghan, Singh, Manisha, Jungbluth, Achim A., Zanzonico, Pat B., Piersigilli, Alessandra, Larson, Steven M., Cheung, Nai-Kong V.
Publicado 2018

γ-Tocotrienol–Loaded Liposomes for Radioprotection from Hematopoietic Side Effects Caused by Radiotherapeutic Drugs

por Lee, Sang-gyu, Kalidindi, Teja Muralidhar, Lou, Hanzhi, Gangangari, Kishore, Punzalan, Blesida, Bitton, Ariana, Lee, Casey J., Vargas, Hebert A., Park, Soobin, Bodei, Lisa, Kharas, Michael G., Singh, Vijay K., Kishore Pillarsetty, Naga Vara, Larson, Steven M.
Publicado 2021

Targeting of radiolabeled J591 antibody to PSMA-expressing tumors: optimization of imaging and therapy based on non-linear compartmental modeling

por Fung, Edward K., Cheal, Sarah M., Fareedy, Shoaib B., Punzalan, Blesida, Beylergil, Volkan, Amir, Jawaria, Chalasani, Sandhya, Weber, Wolfgang A., Spratt, Daniel E., Veach, Darren R., Bander, Neil H., Larson, Steven M., Zanzonico, Pat B., Osborne, Joseph R.
Publicado 2016

The use of single-timepoint images to link administered radioiodine activity (MBq) to a prescribed lesion radiation-absorbed dose (cGy): a regression-based prediction interval tool...

por Mauguen, Audrey, Grewal, Ravinder K., Augensen, Finn, Abusamra, Murad, Mahajan, Sonia, Jayaprakasam, Vetri Sudar, Osborne, Joseph, Haque, Sofia, Wong, Bernadette Z. Y., Ghossein, Ronald A., Fagin, James, Schӧder, Heiko, Tuttle, R. Michael, Ho, Alan, Humm, John L., Larson, Steven M.
Publicado 2023

The risk of exaggerated risk aversion—a life and death struggle for molecular imaging

por Långström, Bengt, Grahnen, Anders, Honoré, Per Hartvig, Borlak, Jürgen, Bergstrom, Mats, Nielsen, Bengt, Vanderheyden, JeanLuc, Watanabe, Yasuyoshi, Josephsson, Raymond, Høilund-Carlsen, Poul F., Schwaiger, Markus, Larson, Steven M., Goldenberg, David M., Melzer, Andreas, Engler, Henry, Hicks, Rodney, Sundin, Anders, Seppänen, Marko, Hedenstierna, Göran, Nordberg, Agneta, Brooks, David
Publicado 2009

Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

por McDevitt, Michael R., Thorek, Daniel L. J., Hashimoto, Takeshi, Gondo, Tatsuo, Veach, Darren R., Sharma, Sai Kiran, Kalidindi, Teja Muralidhar, Abou, Diane S., Watson, Philip A., Beattie, Bradley J., Timmermand, Oskar Vilhemsson, Strand, Sven-Erik, Lewis, Jason S., Scardino, Peter T., Scher, Howard I., Lilja, Hans, Larson, Steven M., Ulmert, David
Publicado 2018

Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

por Kramer, Kim, Pandit-Taskar, Neeta, Kushner, Brian H., Zanzonico, Pat, Humm, John L., Tomlinson, Ursula, Donzelli, Maria, Wolden, Suzanne L., Haque, Sophia, Dunkel, Ira, Souweidane, Mark M., Greenfield, Jeffrey P., Tickoo, Satish, Lewis, Jason S., Lyashchenko, Serge K., Carrasquillo, Jorge A., Chu, Bae, Horan, Christopher, Larson, Steven M., Cheung, Nai-Kong V., Modak, Shakeel
Publicado 2022